InvestorsHub Logo

GangstaRIB

08/30/17 10:58 AM

#35951 RE: Alan Brochstein #35950

75% and 15 day low is much better than 55% and 30 day low. but assuming they covert next year in JUL/AUG the full $1M in notes will cost 133M shares today or ~10% equity and 1.3M later on (assuming 100/1 r/s)

$500K of the first round of notes already went to the MA lab acquisition.

I'm not sure what this round of funding was for either closing out the MA contract or it's going to fund South CA lab.

I'm not sure if this will convert or be paid off. Either way there will be dilution. IMHO 10% equity to get CA off the ground right now is worth it. At this stage in the game it's the only financing option available and even going forward I suspect SGBY will need to lean on some kind of equity based financing going forward. I would like to see them get away from the convertible notes and maybe file an S1 so we attract a long term investor over a 'cash out' convertible note 'bank'. We'll see what happens after the r/s as the share structure stands today an S1 would never fly.

Investor_2016

08/30/17 11:17 AM

#35954 RE: Alan Brochstein #35950

The CEO says that the planned R/S will help attract conventional financing (loans, I assume, rather than shares). Do you agree that a share price above $1 and a lower A/S count will help attract non-toxic investments?

GangstaRIB

08/30/17 4:39 PM

#35984 RE: Alan Brochstein #35950

Total F.U.D. Alan...... (Fear Unknown Doubt)

Maybe WW hasn't answered because you have been sending him mindless ramblings since November of last year... or maybe those emails were never sent.

Does anyone know about the connections between William Waldrop, the SGBY CEO, and penny stock financier Joseph Wade (Joseph Wade Mezey). I reached out to Waldrop, but he didn't respond. If Wade is an investor here, this is going back sub-penny (pre-reverse). Wade is bad news, and he worked with Waldrop at that penny stock failure Waldrop worked at previously.